BioCatalyst

ZYN002 - Cannabidiol Transdermal Gel — catalyst calendar

1 verified catalyst event(s) referencing ZYN002 - Cannabidiol Transdermal Gel, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 i
Phase 2/3 · Fragile X Syndrome
 Zynerba Pharmaceuticals, Inc. ZYN002 - Cannabidiol Transdermal Gel ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.